FCG Investment Company’s Gilead Sciences GILD Stock Holding History

FCG Investment Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$786K	Sell	6,223 -9,317	-60%	-$1.23M	0.27%	74
2026 Q1	$2.17M	Buy	+15,540	New	+$2.18M	0.95%	24
2025 Q3	$2.36M	Sell	21,285 -646	-3%	-$73.4K	1.11%	21
2025 Q2	$2.43M	Buy	21,931 +1,365	+7%	+$145K	1.27%	18
2025 Q1	$2.3M	Buy	20,566 +9,326	+83%	+$962K	1.45%	20
2024 Q4	$1.04M	Buy	11,240 +1,003	+10%	+$90.3K	0.63%	50
2024 Q3	$858K	Buy	10,237 +2,163	+27%	+$165K	0.56%	58
2024 Q2	$554K	Sell	8,074 -1,391	-15%	-$92.8K	0.42%	66
2024 Q1	$693K	Buy	9,465 +2,710	+40%	+$208K	0.55%	59
2023 Q4	$547K	Buy	+6,755	New	+$526K	0.54%	52

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

FCG Investment Company's GILD Position: Q2 2026 in Review

FCG Investment Company reduced its Gilead Sciences (GILD) stake by 60% in Q2 2026, selling an estimated $1.23M and leaving 6,223 shares worth $786K. The position accounts for 0.27% of the portfolio, ranked #74.

FCG Investment Company first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.43M in Q2 2025. 837 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

FCG Investment Company held 6,223 shares of Gilead Sciences worth $786K as of Q2 2026.
FCG Investment Company sold 9,317 Gilead Sciences shares in Q2 2026, an estimated $1.23M.
Gilead Sciences made up 0.27% of FCG Investment Company's portfolio in Q2 2026, its #74 holding.
FCG Investment Company first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
FCG Investment Company's Gilead Sciences position peaked at $2.43M in Q2 2025.
837 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on FCG Investment Company's 13F filing for Q2 2026, filed 13 Jul 2026.